These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2125 related articles for article (PubMed ID: 14528050)

  • 1. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.
    Tsigelny IF; Crews L; Desplats P; Shaked GM; Sharikov Y; Mizuno H; Spencer B; Rockenstein E; Trejo M; Platoshyn O; Yuan JX; Masliah E
    PLoS One; 2008 Sep; 3(9):e3135. PubMed ID: 18769546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.
    Hashimoto M; Masliah E
    Neurochem Res; 2003 Nov; 28(11):1743-56. PubMed ID: 14584828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
    Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
    Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
    Krüger R; Müller T; Riess O
    J Neural Transm (Vienna); 2000; 107(1):31-40. PubMed ID: 10809401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease?
    Lee SJ
    Antioxid Redox Signal; 2003 Jun; 5(3):337-48. PubMed ID: 12880487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of NACP/alpha-synuclein and its role in Alzheimer's disease.
    Iwai A
    Biochim Biophys Acta; 2000 Jul; 1502(1):95-109. PubMed ID: 10899435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y; Miller Y
    ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
    Tabner BJ; Turnbull S; El-Agnaf OM; Allsop D
    Free Radic Biol Med; 2002 Jun; 32(11):1076-83. PubMed ID: 12031892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
    Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
    Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of synucleins in Alzheimer's disease.
    Crews L; Tsigelny I; Hashimoto M; Masliah E
    Neurotox Res; 2009 Oct; 16(3):306-17. PubMed ID: 19551456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
    Masliah E; Rockenstein E; Veinbergs I; Sagara Y; Mallory M; Hashimoto M; Mucke L
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12245-50. PubMed ID: 11572944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein, Abeta and Alzheimer's disease.
    Wirths O; Bayer TA
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):103-8. PubMed ID: 12551731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways.
    Majd S; Power JH; Grantham HJ
    BMC Neurosci; 2015 Oct; 16():69. PubMed ID: 26499115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease.
    Ganguly G; Chakrabarti S; Chatterjee U; Saso L
    Drug Des Devel Ther; 2017; 11():797-810. PubMed ID: 28352155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.
    Tabner BJ; Turnbull S; El-Agnaf O; Allsop D
    Curr Top Med Chem; 2001 Dec; 1(6):507-17. PubMed ID: 11895127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Rocha EM; De Miranda B; Sanders LH
    Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper(II)-induced self-oligomerization of alpha-synuclein.
    Paik SR; Shin HJ; Lee JH; Chang CS; Kim J
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):821-8. PubMed ID: 10359669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 107.